![]() |
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
washingtonpost.com » washingtonpost.com - Technology - Aug 26, 2008
Novavax said yesterday that its bird flu vaccine elicited a robust immune response in humans, moving the biotech a step closer to licensing its pandemic vaccine production system.
Also tagged: licensing, asia, vaccine, united states, bird, moves, to, flu, world health organization, closer, western europe, rockville, glaxosmithkline plc, ge healthcare, royal bank of canada, novavax, novartis ag, sanofi aventis sa, novavax inc